According to a new report published by Allied Market Research, titled, โ€œVenous Thromboembolism Treatment Market: Global Opportunity Analysis and Industry Forecast, 2020-2027” Venous thromboembolism (VTE) is a condition in which a blood clot forms most often in the deep veins of the leg, groin or arm (known as deep vein thrombosis, DVT) and travels in the circulation, lodging in the lungs (known as pulmonary embolism, PE). Together, DVT and PE are known as VTE – a dangerous, potentially deadly medical condition. VTE is a leading cause of death and disability worldwide. A comprehensive scientific review by the WTD steering committee revealed that 10 million cases of VTE occur annually across low-, middle- and high-income countries. Anticoagulant and thrombolytic therapy options are available for the treatment of venous thromboembolism (VTE). Anticoagulant therapy prevents further clot deposition and allows the patientโ€™s natural fibrinolytic mechanisms to lyse the existing clot. Anticoagulant inpatient medications should include heparin or a low-molecular-weight heparin (LMWH), followed by the initiation of an oral coumarin derivative. Growing demand for venous thromboembolism treatment devices is anticipated to drive for venous thromboembolism treatment industry growth over the coming years.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐๐ƒ๐… ๐๐จ๐ฎ๐œ๐ก๐ž๐ซ: https://www.alliedmarketresearch.com/request-sample/11380

COVID-19 Scenario Analysis

The coronavirus COVID-19 is affecting 213 countries and territories around the world. COVID-19 has created new challenges that are requiring manufacturers to innovate at speeds they never have before. Supply chain disruptions, social distancing on high-touch assembly lines, limited ability to travel, and the need for oversight add significant complexity to todayโ€™s processes. The outbreak of coronavirus disease 2019 (COVID-19) has created a global health crisis that has had a deep impact on the manufacturing market there is a shortage in supply of raw materials from Chinese manufacturers which has resulted in a severe demand-supply gap. The manufacturers are further expected to be stranded on raw material orders owing to the logistics industry being significantly impacted due to lockdown amid COVID-19. There has also been a shortage of beds in hospital as the majority of beds are assigned to COVID-19 patients who require critical care. This has all affected the market adversely causing a slowdown in the venous thromboembolism treatment market due to shortage of workforce, supply and manufacturing.

Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, is a common disorder with at least 250,000 new events occurring each year in the United States alone. Treatment of VTE entails anticoagulation, which is achieved initially with the use of a parentally administered anticoagulant followed by a more prolonged course of treatment with an oral vitamin K antagonist. The duration of anticoagulation depends on the clinical assessment of the benefit-risk ratio of prolonged anticoagulation versus the risk of recurrent events.

The introduction of low molecular weight heparins and related inhibitors of factor Xa (such as the pentasaccharide Fondaparinuxโ„ข) have arguably addressed the clinical need for better parenteral anticoagulants. These agents have superior bioavailability and reduced need for monitoring compared to unfractionated heparin. However, the need for orally available anticoagulants to replace warfarin and other vitamin K antagonists in the secondary prophylaxis of VTE persists. Warfarin was introduced into clinical practice in 1954, and to this day it remains the only licensed oral agent for the treatment of VTE.

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ฒ: https://www.alliedmarketresearch.com/purchase-enquiry/11380

The key players profiled in this report include Argon Medical Devices, Arjo, Boston Scientific, Cardinal Health (Medtronic), Cook Medical, DJO Global, Koninklijke Philips N.V., and Stryker.

๐Š๐ž๐ฒ ๐๐ž๐ง๐ž๐Ÿ๐ข๐ญ๐ฌ:

  • This study presents the analytical depiction of the global venous thromboembolism treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global venous thromboembolism treatment market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global venous thromboembolism treatment market growth scenario.
  • Porterโ€™s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global venous thromboembolism treatment market analysis based on competitive intensity and how the competition will take shape in coming years.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง: https://www.alliedmarketresearch.com/request-for-customization/11380

๐Ž๐ญ๐ก๐ž๐ซ ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ:

North America and Europe Menstrual Cup Market: https://www.alliedmarketresearch.com/north-america-and-europe-menstrual-cup-market-A06126

Surgical Robotic System Market: https://www.alliedmarketresearch.com/surgical-robotic-systems-market-A06827

Surgical Drains Market: https://www.alliedmarketresearch.com/wound-drainage-surgical-drains-market-A07517

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โ€œMarket Research Reportsโ€ and โ€œBusiness Intelligence Solutions.โ€ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Leave a comment

Your email address will not be published.